Angiocell™, bone marrow-derived stem cells for treatment of critical limb ischemia

This  study aimed to compare the efficacy of implantation of intramuscular autologous bone marrow mononuclear cells plus mesenchymal stem cell to that of implantation of intramuscular autologous bone marrow mononuclear cells only in patients with chronic critical limb ischemia.